GlassScriptPhysician profile
Lindsey Sollers
NPI 1124797535
$8,534.92
in general payments reported to CMS, 2019-2025
34 companies · $1,609 in 2025
The $1,609 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $1,970 · 2023: $2,466 · 2024: $2,137 · 2025: $1,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,197 · Education: $15.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,196.63 |
| Education | $15.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,451.82 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,293.45 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $1,027.47 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $666.66 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $502.94 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $469.15 | 2021-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $417.98 | 2021-2025 | Jardiance, Tradjenta |
| Pfizer INC. | $302.85 | 2023 | |
| Dexcom, INC. | $266.25 | 2022-2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $239.57 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $208.90 | 2022-2023 | Verquvo, Belsomra, Proquad |
| Sumitomo Pharma America, INC. | $197.20 | 2023-2025 | Gemtesa |
| Harmony Biosciences LLC | $170.22 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $162.65 | 2023-2024 | |
| Amarin Pharma, INC. | $125.74 | 2021-2022 |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Sollers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.